Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies

Factors contributing to hematopoietic recovery following chimeric antigen receptor (CAR) T-cell therapy have not been well studied. In an analysis of 83 patients with hematologic malignancies treated with CAR T-cell therapy, we describe patterns of hematopoietic recovery and evaluate potentially ass...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Blood Adv
Main Authors: Jain, Tania, Knezevic, Andrea, Pennisi, Martina, Chen, Yunxin, Ruiz, Josel D., Purdon, Terence J., Devlin, Sean M., Smith, Melody, Shah, Gunjan L., Halton, Elizabeth, Diamonte, Claudia, Scordo, Michael, Sauter, Craig S., Mead, Elena, Santomasso, Bianca D., Palomba, M. Lia, Batlevi, Connie W., Maloy, Molly A., Giralt, Sergio, Smith, Eric, Brentjens, Renier, Park, Jae H., Perales, Miguel-Angel, Mailankody, Sham
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Hematology 2020
נושאים:
Immunobiology and Immunotherapy
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7422135/
https://ncbi.nlm.nih.gov/pubmed/32780846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002509
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים